Figure 6

Angiotensin-converting enzyme (ACE) activities in aortas obtained from WKY rats and placebo (P)-, candesartan (C)-, candesartan plus amlodipine (C+A)- and candesartan plus HCTZ (C+H)-treated SHR-SP (a). Gene expressions of ACE in aortas obtained from the WKY rats and placebo (P)-, candesartan (C)-, candesartan plus amlodipine (C+A)- and candesartan plus HCTZ (C+H)-treated SHR-SP (b). **P<0.01 vs. placebo-treated SHR-SP. #P<0.05 and ##P<0.01 vs. candesartan-treated SHR-SP.